包装 | 价格(元) |
100mg | 电议 |
250mg | 电议 |
500mg | 电议 |
生物活性 | CDK9-IN-22 is a potentCDK9inhibitor withIC50s of 10.4, 876.2 nM forCDK9,CDK, respectively. CDK9-IN-22 inducesapoptosisand cell cycle arrests at G2/M phase. CDK9-IN-22 decreases the expression of p-RNAPII (S2) andCDK9protein. CDK9-IN-22 shows antiproliferative and aiti-tumor activity[1]. | ||||||||||||||||||||||||||||||||
IC50& Target[1] |
| ||||||||||||||||||||||||||||||||
体外研究 (In Vitro) | CDK9-IN-22 (compound 8 d) (0.1, 0.5, 2.5 μM; 24, 48 h) 在 PANC-1 细胞中以浓度依赖性方式诱导细胞凋亡和细胞周期停滞在 G2/M 期[1 ]. Cell Proliferation Assay[1]
Apoptosis Analysis[1]
Cell Cycle Analysis[1]
Western Blot Analysis[1]
| ||||||||||||||||||||||||||||||||
体内研究 (In Vivo) | CDK9-IN-22 (5, 10, 20 mg/kg; i.p.; every other day for four weeks) 抑制异种移植小鼠模型中的肿瘤生长[1]。
| ||||||||||||||||||||||||||||||||
分子量 | 485.55 | ||||||||||||||||||||||||||||||||
Formula | C28H28FN5O2 | ||||||||||||||||||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||||||||||||||||||
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |